期刊文献+

腹膜透析患者胃肠道症状与心理状况的探讨 被引量:4

下载PDF
导出
摘要 目的观察腹膜透析患者胃肠道症状与心理状况,并分析两者的关系.方法45例腹膜透析患者作为研究对象,均进行胃肠道症状、心理状况等评估.观察患者胃肠道症状及心理状况,分析焦虑抑郁患者与非焦虑抑郁患者透析器对尿素的清除量与体积的比值(kt/V)、体质量指数(BMI)等临床相关指标以及患者心理状况等与胃肠道症状的关系.结果45例腹膜透析患者胃肠道症状评分为(4.65±0.21)分,其中有胃肠道症状37例,占82.22%.45例腹膜透析患者中,抑郁和焦虑患者共计21例,占46.67%.抑郁焦虑患者胃肠道症状评分、Kt/V、舒张压、BMI与非抑郁焦虑患者比较差异具有统计学意义(t=32.7100、34.5975、32.2733、54.6587,P<0.05).依据Pearson相关分析法,胃肠道症状评分与焦虑评分、抑郁评分、BMI呈正相关(r=0.523、0.482、0.256,P<0.05),与Kt/V呈负相关(r=-0.212,P<0.05).结论腹膜透析患者胃肠道症状发生率较高,且不良心理状态会对胃肠道症状产生不利影响.透析过程中,不但需要治疗胃肠道症状,也应结合心理护理干预,改善患者不良心理状态,从而提升透析效果.
作者 朱丽娜
出处 《中国实用医药》 2019年第23期42-44,共3页 China Practical Medicine
  • 相关文献

参考文献5

二级参考文献50

  • 1Qunibi WY. Consequences of hyperphosphatemia in pa-tients with end-stage renal disease (ESRD) [J]. KidneyInt Suppl. Sep, 2004(90) :S8-S12.
  • 2Movilli E, Feliciani A, Camerini C, et al. A high cal-cium- phosphate product is associated with high C-reac-tive protein concentrations in hemodialysis patients[J]. Nephron Clin Pract, 2005,101 (4) :cl61-167.
  • 3Kidney Disease:Improving Global Outcomes CKDMBDWG. KDI-G0 clinical practice guideline for the diagnosis, eval-uation, prevention, and treatment of Chronic KidneyDisease- Mineral and Bone Disorder (CKD-MBD) [J]. Kidneyint. Suppl, 2009(113):S1-130.
  • 4National Kidney F. K/D0QI clinical practice guidelinesfor bone metabolism and disease in chronic kidney dis-ease. Am J kidney dis:the official journal of the Na-tional Kidney Foundation, 2003, 42(4 Suppl 3):S1-201.
  • 5Kong X, Zhang L, Zhang L, et al. Mineral and bone dis-order in Chinese dialysis patients: a raulticenter study[J]. BMC nephrology, 2012, 13:116.
  • 6Navaneethan SD, Palmer SC, Vecchio M, et al. Phosphatebinders for preventing and treating bone disease inchronic kidney disease patients[J]. Cochrane Databasesust Rer, 2011,(2) :CD006023.
  • 7Navaneethan SD, Palmer SC, Craig JC, et al. Benefitsand harms of phosphate binders in CKD: a systematic re-view of randomized controlled trials[J]. Am J kidneydis, 2009,54(4):619-637.
  • 8Scaria PT, Gangadhar R, Pisharody R. Effect of lantha-num carbonate and calcium acetate in the treatment ofhyperphosphatemia in patients of chronic kidney disease[J]. Indian J Pharmacol, 2009, 41 (4): 187-191.
  • 9Block GA, Wheeler DC, Persky MS, et al. Effects of phos-phate binders in moderate CKD[J]. J Am Soc Nephrol,2012,23(8):1407-1415.
  • 10Latham NK, Anderson CS, Lee A, et al. A. randomized,controlled trial of quadriceps resistance exercise andvitamin D in frail older people: the Frailty Interven-tions Trial in Elderly Subjects(FITNESS) [J]. J Am Geri-atr Soc, 2003, 51 ?3) :291-299.

共引文献53

同被引文献48

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部